5 Stocks With Recent Price Strength Amid a Volatile September

A Zacks momentum screen identified five stocks with recent price strength and improving earnings estimates despite September market volatility: EuroDry rose 62.2% over four weeks with its current-year EPS estimate up 49.1%, while Vince Holding gained 40.2% and saw its estimate increase by more than 100%. Nutex Health, TXO Partners and KB Financial gained 14.8%, 10.6% and 10.1%, respectively, alongside upward estimate revisions. The article notes broad market headwinds, with the Dow, S&P 500 and Nasdaq down 3.2%, 1.8% and 1.5% month-to-date amid higher oil prices, sticky inflation, rising Treasury yields and renewed Fed tightening.

Analysis

This is a low-information momentum screen rather than a fundamental catalyst, and its highest-ranked names are precisely where liquidity and estimate-quality risks are greatest. EDRY, VNCE and NUTX are small-cap vehicles in which sparse analyst coverage, wide spreads and limited borrow can turn incremental estimate revisions into reflexive price action; that dynamic can persist for days but is unreliable through the next earnings report. Treat the screen as an alert for diligence, not independent confirmation of durable earnings power.

The cleaner macro transmission is TXO: a sustained crude-price bid raises near-term cash distributions and makes mature, low-decline conventional production more valuable, but also raises the market's required return if rates remain elevated. KB offers a different factor exposure—Korean bank valuation can rerate on shareholder-return policy and a steeper local curve, while credit costs and KRW weakness are the principal offsets. Neither linkage is established by a short-window consensus revision alone.

Contrarian view: buying names nearest their highs after large four-week moves usually loads the portfolio into crowded beta and earnings-revision momentum just as upside surprise hurdles reset. The relevant falsifier is not a technical pullback; it is a second consecutive upward revision cycle accompanied by revenue guidance, cash-flow conversion and liquidity that support the move. Without that, post-earnings de-risking is more likely than further multiple expansion over the next one to three months.

Key Decisions for Investors

• No immediate position in EDRY, VNCE or NUTX. Require next-quarter revenue and EBITDA/operating-cash-flow guidance to rise alongside estimates, plus average daily dollar volume sufficient for institutional execution; otherwise avoid chasing momentum after sharp runs.
• Watch TXO for a 1-3 month tactical long only if WTI holds above its 50-day moving average and management confirms distribution coverage and maintenance-capex discipline. Express with a small cash-equity position rather than options; exit on a sustained WTI breakdown or any distribution-coverage deterioration.
• For Korean financial exposure, prefer a relative-value long KB / short KRE over 3-6 months if KRW stabilizes and Korean credit-cost guidance remains contained. This isolates potential Korea-specific capital-return rerating from broad U.S. regional-bank duration and CRE risk; stop if KB raises provisioning guidance materially.
• Use the next earnings dates as a catalyst filter: initiate only after evidence of a second estimate-revision leg, not before. A miss, reduced guidance, or revenue growth failing to validate the revised earnings outlook should invalidate the momentum thesis immediately.